SynthesisActa neurologica Belgica2024

Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis.

Eslam Mohammed Rabea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.